Other therapeutic components such as pigment epithelium-derived factor (PEDF) [136], adriamycin (ADR) [137], and nucleic acid molecules [138, 139] can be prevented from aggregation and phagocytosis by facile NPs, prolonging their circulation time in vivo and passively targeting tumor tissue through enhanced EPR effects. Here, SERPINF1 is linked to neoplasm.